We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Companion Dog & Loneliness in Elderly Persons (C-KDOG)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04032340
Recruitment Status : Unknown
Verified July 2019 by Assistance Publique - Hôpitaux de Paris.
Recruitment status was:  Not yet recruiting
First Posted : July 25, 2019
Last Update Posted : July 25, 2019
Sponsor:
Collaborator:
Fondation MUTAC
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris

Brief Summary:

Elderly may have problems to create personal connections or to have physical activities in their day- to - day life; loneliness and social isolation may increase fragility in this population. Companion dog presence favours social relations, affective feelings and physical exercises. On the other hand dog presence raises risk of falling and has a cost for its owner. This project seeks to assess positive impacts of companion dog presence in elderly living at home. This transdisciplinar study (general practionners, veterinarians, dog instructors, nurses, researchers) evaluates loneliness and social isolation between elderly with or without a companion dog at home.

Objective:To Evaluate the link between companion dog presence and loneliness in elderly persons living at home Method: An Observational, multicentric, transversal, national, comparative study (elderly with companion dog vs elderly without a dog). 200 subjects needed


Condition or disease Intervention/treatment
Elderly Companion Dog Home Based Loneliness Other: dog presence

Layout table for study information
Study Type : Observational
Estimated Enrollment : 200 participants
Observational Model: Other
Time Perspective: Cross-Sectional
Official Title: Companion Dog Impact on Loneliness and Social Link in Elderly Persons (≥ 75 Years Old) Living at Home : a Comparative Transversal Study
Estimated Study Start Date : January 2020
Estimated Primary Completion Date : January 2022
Estimated Study Completion Date : January 2022

Group/Cohort Intervention/treatment
Elderly with a companion dog
elderly living at home with a dog consulting his family doctor
Other: dog presence
This project seeks to assess positive impacts of companion dog presence in elderly living at home ; to assess loneliness and isolement between eldlery with a companion dog and without, at home

Elderly without a companion dog
elderly living at home without a dog consulting his family doctor



Primary Outcome Measures :
  1. assessment of loneliness using Jong Gierveld scale (11items). [ Time Frame: 5 to 10 days after inclusion visit ]
    emotional dimension (6items) social dimension (5items)


Secondary Outcome Measures :
  1. social isolation [ Time Frame: 5 to 10 days after inclusion visit ]
    Social Network Index french version (http://dx.doi.org/10.13072/midss.464)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   75 Years and older   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Elderly (≥75 years old) living at home, with or without a companion dog, visiting their doctor
Criteria

Inclusion Criteria:

  • person aged ≥ 75years old
  • living at home

Exclusion Criteria:

  • bedridden person
  • person accompanied by any animal, other than a dog
  • EPHAD based (establishments providing care for the dependent elderly)
  • comprehension or reading difficulties in french affecting study participation and scales assessment
  • cognitive, mental ou psychic disorders
  • person under legal protection

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04032340


Contacts
Layout table for location contacts
Contact: FLORENCE CANOUI-POITRINE, MD-PHD 0149813695 florence.canoui-poitrine@aphp.fr

Sponsors and Collaborators
Assistance Publique - Hôpitaux de Paris
Fondation MUTAC
Investigators
Layout table for investigator information
Principal Investigator: FLORENCE CANOUI-POITRINE, MD-PHD APHP CHU HENRI MONDOR
Layout table for additonal information
Responsible Party: Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier: NCT04032340    
Other Study ID Numbers: AP-HP190493
First Posted: July 25, 2019    Key Record Dates
Last Update Posted: July 25, 2019
Last Verified: July 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No